Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

MPN Advances Day 2019 | Objectively measuring responses in MPNs

Nauman Butt • 15 Nov 2019
MPN Advances Day 2019
Myeloproliferative Neoplasms

Nauman Butt, MB BCh, MRCP, MD, FRCPath, Royal Liverpool and Broadgreen University Hospital NHS Trust, Liverpool, UK, outlines the everyday clinical challenges for the management of myeloproliferative neoplasms (MPNs), with a focus on objectively measuring patient response. This interview took place at the Myeloproliferative Neoplasms Conference 2019 in London, UK.

More from Nauman Butt

1:58
MPN Advances Day 2019: highlights
Nauman Butt • 15 Nov 2019
2:50
Establishing standardized guidelines on eosinophilia investigation and management in the UK
Nauman Butt • 17 Nov 2017

Related Videos

2:05
Donor lymphocyte infusion for relapsed myelofibrosis in the post-alloSCT setting
Alex Rampotas • 16 Apr 2024
2:52
JAK inhibitor combination therapy for the treatment of myelofibrosis
Ruben Mesa • 9 Dec 2023
1:30
XPORT-MF-034: selinexor + ruxolitinib combination therapy for MF
John Mascarenhas • 10 Dec 2023
1:38
Pelabresib plus ruxolitinib for the treatment of intermediate- and high-risk myelofibrosis
John Mascarenhas • 10 Dec 2023
The content of VJHemOnc is intended for healthcare professionals